Phylle

With UDI we transfer the products to the OR, then if not used the OR transfers them back to the BB. In Soft we selected the products to a patient, then issued them to the OR. Maybe you can just transfer them to the OR without selecting them. That would eliminate a step. The OR purchased UDI to help them track other tissues, not just human, and other not tissue implants. It seems to be a win win situation for everyone. The company is very cooperative, takes care of building the products, etc. They also keep track of all the licenses of the tissue companies.

I don't know. When we set tissues up, SCC discussed making each tissue an action, but for some reason we didn't go that way. The OR has since purchased a system from UDI which tracks all tissue, human or not, and mechanical devices also. This works GREAT, so SoftBank is moot.

We've used SoftBank for tissues for a few years. They're treated as a noncellular blood product. We did have to make each one an O Neg. They are selected, issued, transfused just like any product, which makes tracking very easy. It is cumbersome when they want 10 cervical spacers.

We also use SoftBank. Feel free to ask any questions.

We have SoftScape. What would you like to know?

We've had an Echo operating since April and love it. We did have some problems with a board but Immucor was very responsive and fixed it. We do mostly type and screens, panels and unit retypes.

We had 2 similar cases like this while we weretesting the ECHO. I'm not thrilled. We're just going to check any discrepancies with tube. We only do weak D on babies. I comfort myself that it's better to give Rh neg blood than vice versa.

We have Soft GUI and love it. It's very versatile - you can personalize it to fit your needs. We love the worksheet. You can also move from 1 function to another easily. We're currently working on an interface with the ECHO, so any hints with that would be welcome.